medroxyprogesterone acetate has been researched along with CKD-MBD in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canalis, E; Mirza, F | 1 |
1 review(s) available for medroxyprogesterone acetate and CKD-MBD
| Article | Year |
|---|---|
Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.
Topics: Acromegaly; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Autoimmune Diseases; Celiac Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucocorticoids; Gonadotropin-Releasing Hormone; Human Growth Hormone; Humans; Hyperparathyroidism, Primary; Hyperthyroidism; Hypogonadism; Inflammatory Bowel Diseases; Medroxyprogesterone Acetate; Multiple Myeloma; Osteoporosis; Thyroxine | 2015 |